Renasant Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-4,684
| Closed | -$286K | – | 151 |
|
2025
Q1 | $286K | Sell |
4,684
-216
| -4% | -$13.2K | 0.19% | 124 |
|
2024
Q4 | $277K | Buy |
4,900
+72
| +1% | +$4.07K | 0.18% | 131 |
|
2024
Q3 | $250K | Buy |
+4,828
| New | +$250K | 0.16% | 144 |
|
2022
Q3 | – | Sell |
-5,366
| Closed | -$413K | – | 174 |
|
2022
Q2 | $413K | Sell |
5,366
-2,208
| -29% | -$170K | 0.34% | 96 |
|
2022
Q1 | $553K | Buy |
7,574
+4,056
| +115% | +$296K | 0.37% | 84 |
|
2021
Q4 | $219K | Buy |
+3,518
| New | +$219K | 0.15% | 188 |
|
2021
Q1 | – | Sell |
-3,373
| Closed | -$210K | – | 183 |
|
2020
Q4 | $210K | Buy |
+3,373
| New | +$210K | 0.17% | 176 |
|